IL20 and cancer: Since the discovery of the IL-20 subfamily of cytokines and receptors, there has been a growing interest in understanding their role in inflammation, particularly cancer, tissue repair, and autoimmunity (Ouyang et al., 2011; Rutz et al., 2014).